| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/07/2010 | EP2170297A2 Duloxetine formulation |
| 04/07/2010 | EP2170296A2 Process for the preparation of a medicament comprising vardenafil hydrochloride trihydrate |
| 04/07/2010 | EP2170295A1 Improved pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof |
| 04/07/2010 | EP2170294A1 Improved pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof |
| 04/07/2010 | EP2170293A2 Combination formulations comprising darunavir and etravirine |
| 04/07/2010 | EP2170292A2 Tableted compositions containing atazanavir |
| 04/07/2010 | EP2170291A1 Pharmaceutical composition containing acetylcholine esterase inhibitor and method for the preparation thereof |
| 04/07/2010 | EP2170288A2 Pellets containing a pharmaceutical substance, method for the production thereof and use of the same |
| 04/07/2010 | EP2170285A2 Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process |
| 04/07/2010 | EP2170280A2 An inhalable composition comprising nicotine |
| 04/07/2010 | EP2170279A1 Methods for producing aripiprazole suspension and freeze-dried formulation |
| 04/07/2010 | EP2170278A2 Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3-{ý(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide |
| 04/07/2010 | EP2170275A2 Dual portion lozenge dosage form |
| 04/07/2010 | EP2170274A1 Compositions, articles and methods comprising tspo ligands for preventing or reducing tobacco-associated damage |
| 04/07/2010 | EP2170270A2 Compositions for delivering medicaments into the lungs, uses thereof |
| 04/07/2010 | EP2170259A1 Slimming composition |
| 04/07/2010 | EP2170233A2 Methods and products for improving wound healing |
| 04/07/2010 | EP2170103A1 Cachexia prevention supplement |
| 04/07/2010 | EP2170098A2 Abrasion-resistant free-flowing glycocyamine-containing mouldings and methods for their production |
| 04/07/2010 | EP2170090A2 Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products |
| 04/07/2010 | EP2170076A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| 04/07/2010 | EP2170073A1 Selective inhibitors for cyclin-dependent kinases |
| 04/07/2010 | EP2170072A1 Farnesoid x receptor agonists |
| 04/07/2010 | EP2170070A2 Ectoparasite control method |
| 04/07/2010 | EP2170069A2 Fly control method |
| 04/07/2010 | EP2170065A1 Diphenyl substituted alkanes |
| 04/07/2010 | EP2170064A1 6.5-pyrrolopiperidine tachykinin receptor antagonists |
| 04/07/2010 | EP2170063A1 Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same |
| 04/07/2010 | EP2170062A1 Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders |
| 04/07/2010 | EP2170061A1 Substituted pyrrolidine compounds with central nervous system activity |
| 04/07/2010 | EP2170060A1 alpha-CHLORO AND alpha-BROMO PHOSPHONATE ANALOGS OF LYSOPHOSPHATIDIC ACID AND METHODS OF MAKING AND USING THEREOF |
| 04/07/2010 | EP2170059A1 Cetp inhibitors derived from benzoxazole arylamides |
| 04/07/2010 | EP2170057A1 5'-substituted adenosynes, preparation thereof and use as inhibitors of s-adenosylmethionine decarboxylase |
| 04/07/2010 | EP2170054A2 Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers |
| 04/07/2010 | EP2170053A1 Compositions and methods of use of phorbol esters |
| 04/07/2010 | EP2170050A1 Short acting phenylalkylamine calcium channel blockers and uses thereof |
| 04/07/2010 | EP2032575B1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivative and its medical use |
| 04/07/2010 | EP1987010B1 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 04/07/2010 | EP1979351B1 6-phenyl-1h-imidazo[4, 5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors |
| 04/07/2010 | EP1948607B1 Cyclopropyl amines as modulators of the histamine h3 receptor |
| 04/07/2010 | EP1934214B1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists |
| 04/07/2010 | EP1845983B1 Ophthalmic compositions and methods of using the same |
| 04/07/2010 | EP1781265B1 Pharmaceutical formulations of potassium atp channel openers and uses thereof |
| 04/07/2010 | EP1673368B1 Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes |
| 04/07/2010 | EP1663245B1 Cephem compounds |
| 04/07/2010 | EP1635818B1 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/07/2010 | EP1597250B1 Indolylmaleimide derivatives |
| 04/07/2010 | EP1590340B1 Inhibitors of histone deacetylase |
| 04/07/2010 | EP1589973B1 Formulation and methods for the treatment of thrombocythemia |
| 04/07/2010 | EP1583559B1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers |
| 04/07/2010 | EP1530470B9 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 04/07/2010 | EP1527050B1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 04/07/2010 | EP1431275B1 Diaryl ether derivative, addition salt thereof, and immunosuppressant |
| 04/07/2010 | EP1313448B1 Topical aminolevulinic acid-photodynamic therapy for acne vulgaris |
| 04/07/2010 | EP1305296B9 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues |
| 04/07/2010 | EP1175497B1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 04/07/2010 | EP1014946B1 Sustained-release liposomal anesthetic compositions |
| 04/07/2010 | CN201436037U Smoking abatement and cigarette replacement device |
| 04/07/2010 | CN1970009B Chinese medicinal suppository for treating piles quickly |
| 04/07/2010 | CN1962678B Adamantane acid andrusol derivatives |
| 04/07/2010 | CN1957733B Chewing gum of Xylitol of kudzuvine root and processing technique thereof |
| 04/07/2010 | CN1934090B Substituted N-cyclohexyl imidazolinones having an MCH-modulatory effect |
| 04/07/2010 | CN1915223B Chewing tablet of compound aluminum magnesium hydroxide, preparation method and method for measuring quality |
| 04/07/2010 | CN1899429B Medicine for removing pigmentary dermatosis |
| 04/07/2010 | CN1872854B Antibiotic in lactam class, and prepartion method |
| 04/07/2010 | CN1813753B Low dose entecavir formulation and use |
| 04/07/2010 | CN1732952B Compound dispersible tablet for treating hypertension |
| 04/07/2010 | CN1617733B Method of treatment of gastrointestinal disease and polymeric composition for use therein |
| 04/07/2010 | CN1582921B Use and medicinal composition of eremophilane lactone for inhibiting hepatitis B virus |
| 04/07/2010 | CN1578647B Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 04/07/2010 | CN1571656B Use of lidocaine in preparation of transdermal patch for treating non-neuropathic pain |
| 04/07/2010 | CN1569869B Chinese chestnut flower flavone compounds |
| 04/07/2010 | CN1545551B Human monoclonal antibody against hepatitis C virus E2 glycoprotein |
| 04/07/2010 | CN101691577A Method for producing aminoacids |
| 04/07/2010 | CN101691410A Marine oligosaccharide chromic compound having function of preventing and treating insulin resistance |
| 04/07/2010 | CN101691390A 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 04/07/2010 | CN101691388A Method for preparing anthracycline cytotoxin compound pharmaceutically acceptable salt and application thereof |
| 04/07/2010 | CN101691384A Phosphate-containing toluylene compound, preparation method thereof and use thereof |
| 04/07/2010 | CN101691373A Medicament for treating erectile dysfunction and premature ejaculation and preparation thereof |
| 04/07/2010 | CN101691372A Aildenafil citrate crystal form C and preparation method and application thereof |
| 04/07/2010 | CN101691371A Pemetrexed thiocarbamide salt and preparation method thereof |
| 04/07/2010 | CN101691370A Triazolo[4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists |
| 04/07/2010 | CN101691367A Piperazine and <2,1-a> isoquinoline compounds with antifungal activity and salts thereof |
| 04/07/2010 | CN101691357A Novel disubstituted imidazolone anti-tumor compounds and preparation method thereof |
| 04/07/2010 | CN101691353A N-Boc-3,5-(E)-diarylidene-4-piperidone and application thereof in preparation of anti-tumor drugs |
| 04/07/2010 | CN101691351A Synthesis method of 4-aminopropenylphenyl-1,4-dihydropyridine and medicinal application thereof |
| 04/07/2010 | CN101691344A Metformin acidic double salt compound and preparation method |
| 04/07/2010 | CN101690823A Method for preparing RGDV-containing cytosine arabinoside conjugate pharmacosome and application as antitumor agent |
| 04/07/2010 | CN101690820A Nano microsphere loading with platinum-containing drugs, hydrogel coated with natural polymers and preparation method and application thereof |
| 04/07/2010 | CN101690815A Novel use of dipeptidyl peptidase-iv inhibitor |
| 04/07/2010 | CN101690814A Traditional Chinese medicine monomer having function of promoting growth of motoneuron |
| 04/07/2010 | CN101690813A Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease and preparation process thereof |
| 04/07/2010 | CN101690812A Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease-infectious bursal disease and preparation process thereof |
| 04/07/2010 | CN101690811A Concentrated freeze-dried yolk antibody composite preparation for infectious bursal disease and preparation process thereof |
| 04/07/2010 | CN101690802A Cervical mucosa inducing gel |
| 04/07/2010 | CN101690800A Externally used medicament for expelling rheumatism, promoting blood circulation and relieving pain and preparation method thereof |
| 04/07/2010 | CN101690785A Bacteriostatic lotion and preparation method thereof |
| 04/07/2010 | CN101690783A External medicine for curing onychomycosis |
| 04/07/2010 | CN101690773A Method for detecting quality of cough stopping syrup |
| 04/07/2010 | CN101690770A Preparation capable of reducing blood pressure and blood lipid and improving human immunity, and preparation method thereof |